Fundz

Reunion Neuroscience Management reported raising $120 Million in an initial SEC Form D filing, from an offering of $66.9 Million

PRIVATEJan 25, 2024

Amount Raised

$120 Million

$120 Million sold, per SEC Form D (first sale Jan 12, 2024)

Round Type

Venture

MorristownBiotechnologyHealth Care

Quick answer

Reunion Neuroscience Management raised $120 Million in a funding round, dated January 12, 2024. Reunion Neuroscience Management is based in Morristown, New Jersey, United States.

How much did Reunion Neuroscience Management raise?
Reunion Neuroscience Management raised $120 Million in a funding round on January 12, 2024.
What does Reunion Neuroscience Management do?
Reunion Neuroscience is a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic therapeutic..
Where is Reunion Neuroscience Management based and how big is it?
Reunion Neuroscience Management is based in Morristown, New Jersey, United States.
Who are the decision-makers at Reunion Neuroscience Management?
Fundz holds 1 contact at Reunion Neuroscience Management. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Reunion Neuroscience Management that raised within 45 days of this round, from Fundz verified event records.

  • Yuva Bio raised $7.5M (Seed) on February 26, 2024.
  • RYNE Biotechnology raised $30M on February 26, 2024.
  • Gasgon Medical raised $4.3M (Seed) on February 26, 2024.
  • adsilico raised $4.4M (Seed) on February 26, 2024.
  • Devonian Health Group raised $2.2M (Seed) on February 26, 2024.
  • Frontier Medicines Corp raised $80M (Series C) on February 25, 2024.

Who to call at Reunion Neuroscience Management, and when

A new round usually means Reunion Neuroscience Management is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Reunion Neuroscience Management raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Reunion Neuroscience Management, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Reunion Neuroscience Management. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Reunion Neuroscience Management

Location

1 HIGH STREET COURT

Morristown, New Jersey, United States

About

Reunion Neuroscience is a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic therapeutic solutions. In August of 2023, Reunion Neuroscience became a private company and in May 2024, the Company completed a Series A financing co-led by MPM BioImpact and Novo Holdings. Reunion is actively investigating the use of its lead product candidate, RE104, in postpartum depression and adjustment disorder, as well as in additional neuropsychiatric indications where there remains a significant unmet need that is not addressed by the current standard of care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Reunion Neuroscience Management raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Reunion Neuroscience Management's next move

See what Strategic adds

Reunion Neuroscience Management raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.